Abstract
Femoropopliteal lesions account for a significant proportion of endovascular interventions for peripheral artery disease in patients with disabling claudication or chronic limb ischemia. The femoropopliteal artery crosses two joint structures (hip and knee joints) and courses through the muscular adductor canal in the thigh, which places the artery at increased biomechanical stress. There is a critical need for stent platforms with a reduced risk of stent fracture while maintaining patency during long-term follow-up. The Supera peripheral stent system has a braided nickel–titanium alloy stent designed to withstand the unique stressors along the course of the femoropopliteal artery. This design may be associated with improved patency in association with reduced stent fracture rates on short- and medium-term follow-up. Further studies, including randomized controlled studies, comparing the Supera interwoven nickel–titanium alloy stent system with other stent platforms and angioplasty alone are needed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 387-395 |
| Number of pages | 9 |
| Journal | Vascular Health and Risk Management |
| Volume | 11 |
| DOIs | |
| State | Published - Jul 13 2015 |
| Externally published | Yes |
Fingerprint
Keywords
- Femoropopliteal atherosclerosis
- Peripheral artery disease
- Stent fracture
- SUPERA interwoven nitinol stent
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Pharmacology (medical)
- Public Health, Environmental and Occupational Health
- Hematology
- Endocrinology, Diabetes and Metabolism
Cite this
Supera self-expanding stents for endovascular treatment of femoropopliteal disease : A review of the clinical evidence. / Bishu, Kalkidan; Armstrong, Ehrin J.
In: Vascular Health and Risk Management, Vol. 11, 13.07.2015, p. 387-395.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Supera self-expanding stents for endovascular treatment of femoropopliteal disease
T2 - A review of the clinical evidence
AU - Bishu, Kalkidan
AU - Armstrong, Ehrin J.
PY - 2015/7/13
Y1 - 2015/7/13
N2 - Femoropopliteal lesions account for a significant proportion of endovascular interventions for peripheral artery disease in patients with disabling claudication or chronic limb ischemia. The femoropopliteal artery crosses two joint structures (hip and knee joints) and courses through the muscular adductor canal in the thigh, which places the artery at increased biomechanical stress. There is a critical need for stent platforms with a reduced risk of stent fracture while maintaining patency during long-term follow-up. The Supera peripheral stent system has a braided nickel–titanium alloy stent designed to withstand the unique stressors along the course of the femoropopliteal artery. This design may be associated with improved patency in association with reduced stent fracture rates on short- and medium-term follow-up. Further studies, including randomized controlled studies, comparing the Supera interwoven nickel–titanium alloy stent system with other stent platforms and angioplasty alone are needed.
AB - Femoropopliteal lesions account for a significant proportion of endovascular interventions for peripheral artery disease in patients with disabling claudication or chronic limb ischemia. The femoropopliteal artery crosses two joint structures (hip and knee joints) and courses through the muscular adductor canal in the thigh, which places the artery at increased biomechanical stress. There is a critical need for stent platforms with a reduced risk of stent fracture while maintaining patency during long-term follow-up. The Supera peripheral stent system has a braided nickel–titanium alloy stent designed to withstand the unique stressors along the course of the femoropopliteal artery. This design may be associated with improved patency in association with reduced stent fracture rates on short- and medium-term follow-up. Further studies, including randomized controlled studies, comparing the Supera interwoven nickel–titanium alloy stent system with other stent platforms and angioplasty alone are needed.
KW - Femoropopliteal atherosclerosis
KW - Peripheral artery disease
KW - Stent fracture
KW - SUPERA interwoven nitinol stent
UR - http://www.scopus.com/inward/record.url?scp=84939812942&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84939812942&partnerID=8YFLogxK
U2 - 10.2147/VHRM.S70229
DO - 10.2147/VHRM.S70229
M3 - Article
VL - 11
SP - 387
EP - 395
JO - Vascular Health and Risk Management
JF - Vascular Health and Risk Management
SN - 1176-6344
ER -